Home » Topics » BioWorld Science

BioWorld Science
RSS

IpY.20 targets p27Kip1 to evade breast cancer resistance driven by CDK4 and CDK2

Dec. 21, 2021

CLIP-170S confers resistance to taxane-based therapy in gastric cancer

Dec. 21, 2021

JAK inhibitors divulged by Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical

Dec. 21, 2021

Biopolar Hongye presents new Janus kinase inhibitors

Dec. 21, 2021

GTPase KRAS mutant inhibitors patented by Genfleet Therapeutics

Dec. 21, 2021

Researchers unveil ACOT13, PTGER2 as candidate genes of autosomal dominant polycystic kidney disease

Dec. 21, 2021

New ATR kinase inhibitors discovered at Shenzhen Life Fountain Biotech

Dec. 21, 2021

Hongyun Biotech identifies new EGFR inhibitors

Dec. 21, 2021

Celularity and Sorrento Therapeutics present preclinical data for CAR19-CYNK immunotherapeutic

Dec. 20, 2021

Discovery of T-036, a novel brain-penetrant GCS inhibitor for the treatment of Gaucher's disease

Dec. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...